The World Health Organization has approved a version of a widely used cholera vaccine that could help address a surge in cases that has depleted the global vaccine stockpile and left poorer countries scrambling to contain epidemics. WHO authorized the vaccine, made by EuBiologics, which also makes the formulation now used, last week. The new version, called Euvichol-S, is a simplified formula that uses fewer ingredients, is cheaper, and can be made more quickly than the old version. The vaccine was shown to be help preventing the diarrheal disease in late stage research conducted in Nepal. WHO’s approval means donor agencies like the vaccines alliance Gavi and UNICEF can now buy it for poorer countries. Leila Pakkala, director of UNICEF’s supply division, said in a statement that the agency will be able to boost supplies by more than 25%. |
Tsinghua Tops Global Ranking in Three Subjects2022 World Artificial Intelligence Conference Held in ShanghaiBeijing's Chaoyang District Builds Cultural Service System with Broader CoverageChina to Improve SciMinistry Ensures Rural Students Not Left BehindUnemployment Rate Falls, Still High in Young GroupsTraditional Chinese Medicine Gains Foothold in 196 Countries, RegionsHawthorn Fruits Enter Mature Season in Liudu, ShandongWorld Robot Conference 2022 Held in BeijingEast China City Makes Progress in Building Child Friendly City